Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Injections × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 21 Breast Neoplasms 14 Myelodysplastic Syndromes 9 Stomach Neoplasms 8 Leukemia, Myelomonocytic, Chronic 7 Sarcoma 6 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Non-Small-Cell Lung 5 Uterine Cervical Neoplasms 4 Recurrence 4 Neoplasms 4 Melanoma 4 Leukemia, Monocytic, Acute 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Biliary Tract Neoplasms 4 Advanced Solid Tumour 4 Stomatitis 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Mucositis 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Transitional Cell 3 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoma, T-Cell, Peripheral 2

Interventions

Temozolomide 136 Bevacizumab 75 Radiotherapy 67 Magnetic Resonance Spectroscopy 21 Irinotecan 18 pembrolizumab 16 Radiation 16 Lomustine 16 Carmustine 15 Surgical Procedures, Operative 11 Nivolumab 10 Erlotinib Hydrochloride 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Aminolevulinic Acid 9 Specimen Handling 8 Carboplatin 8 Cilengitide 7 Sunitinib 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Radiosurgery 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Filgrastim 5 Etoposide 5 Celecoxib 5 Topotecan 4 Tamoxifen 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06598787 2025-05-07

A Study of BL-B01D1 in Patients With Recurrent Glioblastoma

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡